VEGFA and cancer: Considering instead drug sequences, the administration of ICIs at the failure of antiangiogenics could be penalized by the accrual of immunosuppressive cells such as MDSCs, which associate with resistance to the VEGF blockade and an immune hostile milieu always paralleling progressing cancers [86,87].